Akesa appoints supply chain and compliance leader Priscilla Thiyageas to drive APAC expansion
Home > Akesa secures pharmaceutical supply chain executive

Akesa secures pharmaceutical supply chain executive

Akesa appoints supply chain and compliance leader Priscilla Thiyageas to drive the company’s APAC expansion.

Akesa, a clinical trial supply and pharmaceutical services provider, has appointed experienced pharmaceutical executive Priscilla Thiyageas as Supply Chain and Quality Director to lead the company’s expansion into the Asia-Pacific region.

Ms Thiyageas joins Akesa with more than 15 years’ experience in pharmaceutical supply chain management, operational strategy, and regulatory compliance. Having held senior roles at leading pharmaceutical organisations, including IDT Australia and CSL, Ms Thiyageas has led large-scale production, quality and operational programs in highly regulated environments.

Ms Thiyageas’ appointment comes amid growing demand for clinical trial supply services in APAC, a region that now represents a significant and expanding share of global research activity.

“The APAC region presents increasing opportunities for clinical research but also brings regulatory complexity and operational risk. Our expansion is not just about navigating logistics—it’s about ensuring we deliver compliant, resilient supply chain solutions that uphold the integrity of clinical trials,” said George Vlachos, Co-CEO of Akesa.

“Priscilla brings deep experience in managing pharmaceutical operations across diverse and highly regulated markets. Her leadership will be instrumental in enhancing our service delivery and supporting partners across the region,” Mr Vlachos added.

In her new role, Ms Thiyageas will lead Akesa’s supply chain strategy, regulatory compliance, and quality assurance functions across the region.

“The Asia-Pacific region is diverse and fast-moving, with varying regulatory requirements and logistical challenges,” said Priscilla Thiyageas. “Akesa is taking a proactive approach to strengthening its regional capabilities, and I look forward to contributing to its continued growth and compliance leadership.”


About AKESA

Founded in 2014, Akesa is a leading clinical trial supply and pharmaceutical services company based in Australia. With a deep understanding of the APAC market, the company provides tailored sourcing, procurement, and logistics solutions to support clinical research across the region and globally. Akesa’s expertise in pharmaceutical distribution and supply chain management ensures that clinical trials have access to the critical medicines they need.

Author

Nicholas Brittain - Marketing Director, Akesa

Nick Brittain

Chief Operating Officer

  • Akesa targets emissions cuts, reduces supply waste

    Going beyond sustainability to drive alternative pathways to medicine access

  • Akesa and Rock8 partnership to unlock access to pharmaceutical product for APAC clinical trials

    Akesa partners with Rock8 Science to boost pharmaceutical access for APAC clinical trials, improving supply chain transparency and trial readiness across the region.

  • Clinical trial documentation: Challenges, solutions, and best practices

    Explore the critical role of documentation in clinical trials, the types of documents required, challenges in obtaining them, and best practices for ensuring compliance and quality.

  • Akesa supports inclusion at FIDA 2024 Grand Final Day

    Akesa has announced its support for The Football Integration Development Association (FIDA) 2024 Grand Final Day.

    Privacy Overview

    This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.